Posted in | News | Gold | Mining Business

Stellar AfricaGold Identifies New Quartz Veins and Sheared System at Balandougou Project

John Cumming, President and Chief Executive Officer of Stellar AfricaGold Inc., (TSX VENTURE:SPX) ("Stellar" or the "Company") announces:

NEW QUARTZ VEINS EXPOSED AT BALANDOUGOU

The Company is pleased to report that field crews at the Balandougou Gold Project in Guinea have reported that while cutting an access road to the future bulk sample gravity plant site a new quartz veins and sheared system was exposed 200 metres north-east of the B3 sheared zone. The new vein system appears to be running NE-SW and is parallel to Zone B1 and perpendicular to Zone B3.

This new system is consistent with the prior structural analysis (AECOM, 2011) which suggested that the gold mineralized structures identified in sectors B1 and B3 were part of a connected system of shear zones with the sector B1 mineralization contained within a NE-SW striking shear zone with a senestral movement and the sector B3 mineralization contained within a NW-SE striking shear zone with a dextral movement. Consequently, the gold-mineralized veins present in sector B1 and B3 belong to the oblique shear veins geometry commonly found in shear zones areas.

COMMENTARY

Maurice Giroux, Stellar AfricaGold VP Exploration and COO stated: "This new discovery near Zone B3 highlights the importance of continued exploration to the expansion of the gold mineralization at Balandougou's Solotomo discovery site. The interpreted structural geometry of the area suggests that there is considerable potential for discovering additional gold-mineralized shear zones in the vicinity of Zones B3 and B1."

The Company's field crew will proceed shortly to a preliminary assessment and sampling of this new quartz veins structure.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.